Longitudinal evaluation of manufacturer-specific differences for high-sensitive CRP EQA results

BackgroundC-reactive protein (CRP) is an established serum biomarker for different pathologies such as tissue injury and inflammatory events. One rising area of interest is the incorporation of low concentrations of CRP, so called high-sensitive (hs-) CRP, in the risk assessment and treatment monito...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Nathalie Weiss, Laura Vierbaum, Marcel Kremser, Anne Kaufmann-Stoeck, Silke Kappler, Silvia Ballert, Kathrin Kabrodt, Klaus-Peter Hunfeld, Ingo Schellenberg
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Frontiers Media S.A. 2024-08-01
Colecção:	Frontiers in Molecular Biosciences
Assuntos:	hsCRP external quality assessment scheme (EQA) proficiency testing (PT) harmonization cardiovascular diseases
Acesso em linha:	https://www.frontiersin.org/articles/10.3389/fmolb.2024.1401405/full
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!